Acorda Therapeutics (ACOR) Income Statement

Click line-items for a historical chart and %

Gross product sales
Less: discounts and allowances
Net sales	128.51M
License and royalty revenue	2.26M
Total net revenues	135.61M
Cost of sales	27.64M
Research and development	54.78M
Selling, general and administrative	54.81M
Total operating expenses	141.09M
Operating income (loss)	-5.47M
Interest and amortization of debt discount expense	-4.4M
Interest income	46K
Total other expense (net)	-4.54M
Loss before taxes	-10.01M
Provision for income taxes	-3.02M
Net loss	-12.73M
Net loss per share-basic (earnings per share)	-0.28
Net loss per share-diluted (earnings per share)	-0.28
Weighted average common shares outstanding used in computing net loss per share-basic (in shares)	45.38M
Weighted average common shares outstanding used in computing net loss per share-diluted (in shares)	45.38M

Entities mentioned with ACOR

View All Entities